Skip to main content

Antonio González Fernández

Institutions of which they are part

Senior researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Antonio González Fernández

Institutions of which they are part

Senior researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Projects

Unitat de Recerca en Malalties Hepatobiliars

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit, Antonio González Fernández, Lluis Castells Fusté, Silvia Sauleda Oliveras, Lluís Palenzuela Díaz, Maria Buti Ferret, Josep Quer Sivila, Maria Nieves Martell Pérez-Alcalde, Juan Ignacio Esteban Mur, David Tabernero Caellas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 54080
Reference: 2009 SGR 383
Duration: 01/01/2010 - 30/04/2014

Utilidad de la PCR bacteriana en el diagnostico de la peritonitis bacteriana espontánea del cirrotico.

IP: Joan Genescà Ferrer
Collaborators: Antonio González Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 15205.61
Reference: 01/1390
Duration: 17/07/2001 - 31/12/2002

Estudio longitudinal de la expresión génica diferencial de la alteración vascular esplácnica en el modelo experimental de hipertensión portal de rata. Papel de los mecanismos de angiogénesis

IP: Joan Genescà Ferrer
Collaborators: Antonio González Fernández, Maria Nieves Martell Pérez-Alcalde
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 83490
Reference: SAF2006-03714
Duration: 01/10/2006 - 30/09/2009

Ministerio de Ciencia

Miocardiopatía del paciente cirrótico: Importancia clínica y relación fisiopatológica con citocinas y óxido nítrico.

IP: Antonio González Fernández
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 39666.8
Reference: 98/1229
Duration: 01/11/1998 - 01/11/1999

Related news

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy.

Related professionals

Betina Biagetti Biagetti

Betina Biagetti Biagetti

Diabetes and Metabolism
Read more
Mireia  Beltran  Porres

Mireia Beltran Porres

Growth and Development
Read more
Joana Ramis Garcia

Joana Ramis Garcia

Research technician
Pharmacokinetic Nanoparticles
Read more
Adrià  Tomé Cabello

Adrià Tomé Cabello

Medium Grade Technician
Technological Infrastructure Unit
Digital Transformation Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.